This week’s Bulls N’ Bears ASX Runner of the Week is… Oceana Lithium, after it raised to fill its coffers, ahead of base ...

Biotechnology company Regeneron will acquire 23andMe out of bankruptcy for $256 million, with a plan to keep the DNA-testing company running without interruption and uphold its privacy-protection ...

FBT selects 30 biotechnology stocks based on sales, sales as a percentage of R&D expenditures, and R&D growth compared to three years ago. The ETF launched 19 years ago and has delivered ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

Biotechnology company Regeneron Pharmaceuticals is buying 23andMe for $256 million, two months after the genetic testing company filed for Chapter 11 bankruptcy protection. In March 23andMe said ...

Our free stock report includes 4 warning signs investors should be aware of before investing in Fortress Biotech. Read for free now. Revenue exceeded analyst estimates by 13%. Earnings per share ...

This includes 400 hours of hands-on biotech and life sciences training, mentorship, free on-campus housing, and a stipend. Each student will be matched with three mentors: a faculty member, an ...